Michael O Breckwoldt Selected Research

Michael O Breckwoldt Research Topics

Disease

14	Neoplasms (Cancer) 10/2023 - 01/2017
11	Glioma (Gliomas) 11/2023 - 01/2018
6	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2020
5	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2018
3	Multiple Sclerosis 12/2023 - 04/2008
3	Inflammation (Inflammations) 01/2019 - 11/2008
2	Stroke (Strokes) 08/2023 - 11/2008
1	Chromothripsis 12/2021
1	Medulloblastoma 12/2021
1	Thrombosis (Thrombus) 01/2021
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Adenocarcinoma of Lung 12/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Melanoma (Melanoma, Malignant) 10/2019
1	Coma (Comas) 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Necrosis 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Cerebral Malaria 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Neuroinflammatory Diseases 11/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2014
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2012
1	Vasculitis (Vasculitides) 01/2012
1	Brain Ischemia (Cerebral Ischemia) 11/2008
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2008

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2008
4	Peroxidase (Myeloperoxidase)IBA 01/2019 - 04/2008
3	Protein Subunit VaccinesIBA 10/2023 - 01/2021
3	VaccinesIBA 10/2023 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 01/2021
3	GadoliniumIBA 10/2021 - 11/2008
2	AntigensIBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2018
2	EnzymesIBA 01/2012 - 11/2008
1	CyclodextrinsIBA 11/2023
1	Toll-Like Receptor 7IBA 11/2023
1	Lysine (L-Lysine)FDA Link 10/2023
1	Histones (Histone)IBA 10/2023
1	Methionine (L-Methionine)FDA Link 10/2023
1	PlasticsIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	ferric oxide (iron oxide)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	CarbonIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	IonsIBA 12/2021
1	Thrombin FDA Link 01/2021
1	Codon (Codons)IBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Dabigatran FDA Link 01/2021
1	OvalbuminIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2020
1	nintedanibIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	NAD (NADH)IBA 01/2020
1	Melanins (Melanin)IBA 10/2019
1	Cytostatic AgentsIBA 01/2019
1	Myelin ProteinsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	RG7388IBA 01/2019
1	trametinibIBA 01/2019
1	gadodiamide (Omniscan)FDA Link 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	PeroxiredoxinsIBA 01/2018
1	Mitogen-Activated Protein Kinase 14IBA 01/2018
1	PolyaminesIBA 01/2018
1	IronIBA 01/2017
1	CalciumIBA 05/2014
1	Contrast MediaIBA 01/2012
1	salicylhydroxamic acid (SHAM)IBA 01/2012
1	Gadolinium DTPA (Magnevist)FDA Link 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008
1	diethylenetriamineIBA 11/2008

Therapy/Procedure

9	Therapeutics 01/2023 - 11/2008
5	Radiotherapy 12/2023 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Immunotherapy 01/2023 - 01/2020
1	Thrombectomy 08/2023
1	Heavy Ion Radiotherapy 12/2021
1	Lasers (Laser) 01/2021
1	Salvage Therapy 01/2019
1	Intraperitoneal Injections 01/2012